Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Research & Development: 2019-2024

Historic Research & Development for Burning Rock Biotech (BNR) over the last 6 years, with Dec 2024 value amounting to -$31.8 million.

  • Burning Rock Biotech's Research & Development fell 31.92% to $71.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.5 million, marking a year-over-year decrease of 129.83%. This contributed to the annual value of -$31.8 million for FY2024, which is 34.89% up from last year.
  • According to the latest figures from FY2024, Burning Rock Biotech's Research & Development is -$31.8 million, which was up 34.89% from -$48.9 million recorded in FY2023.
  • Over the past 5 years, Burning Rock Biotech's Research & Development peaked at -$31.8 million during FY2024, and registered a low of -$61.2 million during FY2022.
  • In the last 3 years, Burning Rock Biotech's Research & Development had a median value of -$48.9 million in 2023 and averaged -$47.3 million.
  • Per our database at Business Quant, Burning Rock Biotech's Research & Development plummeted by 77.97% in 2020 and then surged by 34.89% in 2024.
  • Yearly analysis of 5 years shows Burning Rock Biotech's Research & Development stood at -$40.5 million in 2020, then crashed by 42.70% to -$57.7 million in 2021, then declined by 5.96% to -$61.2 million in 2022, then grew by 20.09% to -$48.9 million in 2023, then spiked by 34.89% to -$31.8 million in 2024.